根据名称进行药物检索

Paliperidone injection与迟发性运动障碍

Paliperidone injection与迟发性运动障碍安全配伍检测的结果。

检测结果:

Paliperidone injection <> 迟发性运动障碍

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

神经抑制剂可沉淀物的症状迟发运动障碍(TD)，一个综合症组成的节奏非自愿流动行各种涉及舌头上，脸上，嘴，嘴唇，下巴，和/或干和四肢，以下慢性使用至少几个月，但经常年。老年患者，特别是妇女，最容易受到影响。两者的发展风险的综合症的可能性，它将成为不可逆转的增加的持续时间和累积总剂量的抗精神病药物治疗给药。然而，患者可以不经常出现症状之后相对较短处理时间在低剂量。如果TD发生在精神病治疗，迅速撤出犯罪代理人或至少有一个降低的剂量应该加以考虑。 TD症状可能会变得更加严重的后停药或用量减少，但是可以逐渐提高了几个月到几年。在患有先前存在的药物诱发的TD、发起或增加剂量的抗精神病药物治疗可以暂时掩蔽症状TD但最终可能会恶化的情况。较新的、非典型的神经抑制剂(例如，利培酮、硫平、奥氮平)往往是相关的一个基本上降低风险的诱导TD并被视为首选的药物的患者正在接受治疗的精神病。

来源

Pinder RM, Brogden RN, Swayer R, Speight TM, Spencer R, Avery GS "Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry." Drugs 12 (1976): 1-40
Yesavage JA, Tanke ED, Sheikh JI "Tardive dyskinesia and steady-state serum levels of thiothixene." Arch Gen Psychiatry 44 (1987): 913-5
"Product Information. Risperdal (risperidone)." Janssen Pharmaceutica, Titusville, NJ.
Ghelber D, Belmaker RH "Tardive dyskinesia with quetiapine." Am J Psychiat 156 (1999): 796-7
"Product Information. Abilify (aripiprazole)." Bristol-Myers Squibb, Princeton, NJ.
Little JT, Jankovic J "Tardive myoclonus." Mov Disord 2 (1987): 307-11
"Product Information. Orap Tablets (pimozide)." Gate Pharmaceuticals, Sellersville, PA.
"Product Information. Zyprexa (olanzapine)." Lilly, Eli and Company, Indianapolis, IN.
"Product Information. Geodon (ziprasidone)." Pfizer US Pharmaceuticals, New York, NY.
Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM "Clozapine in tardive dyskinesia - observations from human and animal model studies." J Clin Psychiatry 55 (1994): 102-6
Yassa R, Mohelsky HE "Tardive dyskinesia in thiothixene treatment ." J Clin Psychiatry 46 (1985): 151
"Product Information. Navane (thiothixene)." Roerig Division, New York, NY.
Branchey MH, Branchey LB, Richardson MA "Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients." Am J Psychiatry 138 (1981): 608-12
de Leon J, Moral L, Camunas C "Clozapine and jaw dyskinesia: a case report." J Clin Psychiatry 52 (1991): 494-5
Pakkenberg H, Fog R "Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both." Arch Neurol 31 (1974): 352-3
Gwinn KA, Caviness JN "Risperidone-induced tardive dyskinesia and parkinsonism." Mov Disord 12 (1997): 119-21
Meltzer HY, Luchins DJ "Effect of clozapine in severe tardive dyskinesia: a case report." J Clin Psychopharmacol 4 (1984): 286-7
Bransgrove LL, Kelly MW "Movement disorders in patients treated with long-acting injectable antipsychotic drugs." Am J Hosp Pharm 51 (1994): 895-9
Elliott ES, Marken PA, Ruehter VL "Clozapine-associated extrapyramidal reaction." Ann Pharmacother 34 (2000): 615-8
Friedman JH "Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases." Mov Disord 9 (1994): 321-4
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM "Pharmacotherapy: A Pathophysiologic Approach 4th" Stamford, CT: Appleton & Lange (1999):
Narendran R, Young CM, Pato MT "Possible risperidone-induced tardive dystonia." Ann Pharmacother 34 (2000): 1487-8
Peabody CA, Brody D, Warner MD "Tardive dyskinesia after low-dose haloperidol." Biol Psychiatry 22 (1987): 111-2
"Product Information. Haldol (haloperidol)." McNeil Pharmaceutical, Raritan, NJ.
Lamberti JS, Bellnier T "Clozapine and tardive dystonia." J Nerv Ment Dis 181 (1993): 137-8
"Product Information. Loxitane C Oral Concentrate (loxapine)" Watson Laboratories Inc, Corona, CA.
"Product Information. Seroquel (quetiapine)." Zeneca Pharmaceuticals, Wilmington, DE.
Riddle MA, Hardin MT, Towbin KE, et al "Tardive dyskinesia following haloperidol treatment in Tourette's syndrome." Arch Gen Psychiatry 44 (1987): 98-9
Dave M "Tardive oculogyric crises with clozapine." J Clin Psychiatry 55 (1994): 264-5
"Product Information. Clozaril (clozapine)." Novartis Pharmaceuticals, East Hanover, NJ.
Heel RC, Brogden RN, Speight TM, Avery GS "Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent." Drugs 15 (1978): 198-217
Kopala LC, Honer WG "Schizophrenia and severe tardive dyskinesia responsive to risperidone." J Clin Psychopharmacol 14 (1994): 430-1
Buzan RD "Risperidone-induced tardive dyskinesia." Am J Psychiatry 153 (1996): 734-5
Dave M "Clozapine-related tardive dyskinesia." Biol Psychiatry 35 (1994): 886-7
"Product Information. Moban (molindone)." Gate Pharmaceuticals, Sellersville, PA.
Bruun RD "Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder." Am J Psychiatry 145 (1988): 621-4
Portnoy RA "Hyperkinetic dysarthria as an early indicator of impending tardive dyskinesia." J Speech Hear Disord 44 (1979): 214-9
Mahmood T, Clothier EB, Bridgman R "Risperidone-induced extrapyramidal reactions." Lancet 346 (1995): 1226
Herran A, Vazquez-Barquero JL "Tardive dyskinesia associated with olanzapine." Ann Intern Med 131 (1999): 72
Woerner MG, Sheitman BB, Lieberman JA, Kane JM "Tardive dyskinesia induced by risperidone?" Am J Psychiatry 153 (1996): 843
Owens DGC "Extrapyramidal side effects and tolerability of risperidone - a review." J Clin Psychiatry 55 Suppl (1994): 29-35
Small JG, Milstein V, Marhenke JD, Hall DD, Kellams JJ "Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis." J Clin Psychiatry 48 (1987): 263-7